A Phase II, Randomized, Single-dose, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety and Pharmacokinetic Profile of the CollaRx Bupivacaine Implant in Patients After Gastrointestinal Surgery.
Phase of Trial: Phase II
Latest Information Update: 28 Apr 2015
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Innocoll
- 26 Feb 2010 Actual number of patients (7) added as reported by ClinicalTrials.gov record.
- 26 Feb 2010 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 15 Apr 2008 The expected completion date for this trial is now 1 Apr 2009 according to ClinicalTrials.gov.